Log in to save to my catalogue

Bleeding Risk During Colorectal Endoscopic Mucosal Resection With Continued Anticoagulant Therapy: A...

Bleeding Risk During Colorectal Endoscopic Mucosal Resection With Continued Anticoagulant Therapy: A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_39897323

Bleeding Risk During Colorectal Endoscopic Mucosal Resection With Continued Anticoagulant Therapy: A Multicenter Study

About this item

Full title

Bleeding Risk During Colorectal Endoscopic Mucosal Resection With Continued Anticoagulant Therapy: A Multicenter Study

Publisher

United States

Journal title

Curēus (Palo Alto, CA), 2025-01, Vol.17 (1), p.e76753

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Background and aims Endoscopic mucosal resection (EMR) is a standard preventive method for colorectal cancer. Managing patients on anticoagulants during EMR is challenging because of balancing bleeding and thrombotic risks. Updated guidelines recommend continuing anticoagulants over heparin bridging; however, data on bleeding risks with continuing...

Alternative Titles

Full title

Bleeding Risk During Colorectal Endoscopic Mucosal Resection With Continued Anticoagulant Therapy: A Multicenter Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_39897323

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_39897323

Other Identifiers

ISSN

2168-8184

E-ISSN

2168-8184

DOI

10.7759/cureus.76753

How to access this item